• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国发展生物经济的新型创新生态系统。

New innovative ecosystems in France to develop the Bioeconomy.

机构信息

IAR The French Bioeconomy Cluster, 50-52 bd Brossolette, 02 930 Laon France.

Open Innovation Platform BRI, Pomacle France.

出版信息

N Biotechnol. 2018 Jan 25;40(Pt A):113-118. doi: 10.1016/j.nbt.2017.07.009. Epub 2017 Aug 9.

DOI:10.1016/j.nbt.2017.07.009
PMID:28801256
Abstract

The cluster's policy initiated in France in 2005 was a formidable opportunity to boost innovation in the bioeconomy and to develop innovation platforms allowing industrial demonstration and feasibility at technology readiness level (TRL) from 5 to 9. The IAR Cluster (Industries and Agro-Resources), based in the Hauts-de-France and Grand Est regions is completely dedicated to the bioeconomy. IAR's work has contributed to build a complete innovation ecosystem on bioeconomy by opening up relationships between actors along the full value chain. It also facilitated investments in new platforms and programs through public-private partnerships. The Biorefinery of Pomacle is a good illustration of such a collective approach. The role of regional and national public partners is essential to succeed in this development which requires a long term strategy and support.

摘要

该集群的政策于 2005 年在法国启动,这是一个促进生物经济创新和发展创新平台的绝佳机会,可将工业示范和可行性从技术准备水平 (TRL) 5 提高到 9。位于上法兰西大区和大东部大区的 IAR 集群(工业和农业资源)完全致力于生物经济。IAR 的工作通过在整个价值链上建立参与者之间的关系,为构建完整的生物经济创新生态系统做出了贡献。它还通过公私合作伙伴关系促进了新平台和项目的投资。Pomacle 的生物炼制厂就是这种集体方法的一个很好的例证。区域和国家公共合作伙伴的作用对于成功开展这项需要长期战略和支持的发展至关重要。

相似文献

1
New innovative ecosystems in France to develop the Bioeconomy.法国发展生物经济的新型创新生态系统。
N Biotechnol. 2018 Jan 25;40(Pt A):113-118. doi: 10.1016/j.nbt.2017.07.009. Epub 2017 Aug 9.
2
What kind of innovation policy does the bioeconomy need?生物经济需要什么样的创新政策?
N Biotechnol. 2018 Jan 25;40(Pt A):82-86. doi: 10.1016/j.nbt.2017.04.003. Epub 2017 Apr 27.
3
Spanish strategy on bioeconomy: Towards a knowledge based sustainable innovation.西班牙的生物经济战略:迈向基于知识的可持续创新。
N Biotechnol. 2018 Jan 25;40(Pt A):87-95. doi: 10.1016/j.nbt.2017.05.006. Epub 2017 May 25.
4
The origins of the bioeconomy in the European Union.欧盟生物经济的起源。
N Biotechnol. 2018 Jan 25;40(Pt A):20-24. doi: 10.1016/j.nbt.2017.04.002. Epub 2017 Apr 12.
5
An efficient agro-industrial complex in Almería (Spain): Towards an integrated and sustainable bioeconomy model.阿尔梅里亚(西班牙)高效的农工综合体:迈向综合和可持续的生物经济模式。
N Biotechnol. 2018 Jan 25;40(Pt A):103-112. doi: 10.1016/j.nbt.2017.06.009. Epub 2017 Jul 8.
6
Destination bioeconomy - The path towards a smarter, more sustainable future.目的地生物经济——通向更智能、更可持续未来的道路。
N Biotechnol. 2018 Jan 25;40(Pt A):140-143. doi: 10.1016/j.nbt.2017.05.010. Epub 2017 Jun 3.
7
Development of health biotechnology in developing countries: can private-sector players be the prime movers?发展中国家的健康生物技术发展:私营部门能否成为主要推动者?
Biotechnol Adv. 2012 Nov-Dec;30(6):1589-601. doi: 10.1016/j.biotechadv.2012.05.002. Epub 2012 May 19.
8
Bio-based Industries Joint Undertaking: The catalyst for sustainable bio-based economic growth in Europe.生物基产业联合组织:推动欧洲可持续生物基经济增长的催化剂。
N Biotechnol. 2018 Jan 25;40(Pt A):31-39. doi: 10.1016/j.nbt.2017.06.002. Epub 2017 Jun 27.
9
The bioeconomy in Poland within the context of the European Union.波兰的生物经济在欧盟范围内。
N Biotechnol. 2018 Jan 25;40(Pt A):96-102. doi: 10.1016/j.nbt.2017.06.003. Epub 2017 Jun 21.
10
The biotechnology and bioeconomy landscape in Malaysia.马来西亚的生物技术和生物经济格局。
N Biotechnol. 2018 Jan 25;40(Pt A):52-59. doi: 10.1016/j.nbt.2017.06.004. Epub 2017 Jun 28.

引用本文的文献

1
A New Conceptual 'Cylinder' Framework for Sustainable Bioeconomy Systems and Their Actors.可持续生物经济系统及其参与者的新概念性“圆柱体”框架
J Agric Environ Ethics. 2021;34(2):11. doi: 10.1007/s10806-021-09850-7. Epub 2021 Apr 1.